Voltadvance 25mg Anti-inflammatory 30 Tablets

Voltadvance 25mg Anti-inflammatory 30 Tablets it's a anti-inflammatory and pain-relieving medicine in film-coated tablets. Each tablet contains diclofenac sodium 25 mg, the active ingredient that gives the class its name.

The diclofenac belongs to non-steroidal anti-inflammatory drugs, NSAIDs, and works by inhibiting the synthesis of prostaglandins. In this formulation it is present in the saline form sodium, which is the one declared by the owner's RCP. The dosage from 25 mg it is the low one in the range, designed for short-term use without a prescription.

The declared scope of use is that of pains of various kinds: joint pain, lumbago, muscle pain, headache e toothache, menstrual pain. The tablets are film-coated and swallowed whole.

Voltadvance is a brand of Haleon. The packaging is from 30 tablets in OPA, aluminum and PVC blisters, and the range includes packs of 10 and 20 tablets and sachets of powder for oral solution at the same dosage.

INDICATIONS

Why is Voltadvance 25mg Anti-inflammatory 30 Tablets used? What is it for?

Pain of various kinds such as, for example, joint pain, lumbago, muscle pain, headaches and toothaches, menstrual pain.

ACTIVE INGREDIENTS AND EXCIPIENTS

What is the composition of Voltadvance 25mg Anti-inflammatory 30 Tablets?

Active ingredient
One film-coated tablet contains diclofenac sodium 25 mg.

Excipients
Potassium bicarbonate, mannitol, sodium lauryl sulfate, crospovidone, magnesium stearate, glycerol dibeenate, Clear Opadry composed of hypromellose and macrogol.

DOSAGE

How to take Voltadvance 25mg Anti-inflammatory 30 Tablets?

Adults and adolescents over 14 years: 1-3 coated tablets per day, with meals, even 2 in a single administration. The maximum daily dose is 75 mg.

The coated tablets should be swallowed whole, with water or another liquid.

Do not exceed 3 days of treatment.

CONTRAINDICATIONS AND SIDE EFFECTS

When should Voltadvance 25mg Anti-inflammatory 30 Tablets not be used and what side effects can it cause?

Contraindications
Hypersensitivity to the active substance or to any of the excipients. Active gastrointestinal ulcer, bleeding or perforation. History of recurrent peptic ulcer. Severe liver failure or severe kidney failure. Overt congestive heart failure, NYHA class II to IV. Last trimester of pregnancy and breastfeeding. The medicine should not be given to children under 14 years of age.

Side effects
Side effects mainly concern the gastrointestinal system, the liver, the kidney, the cardiovascular system, the blood and the skin. They can be minimized by using the lowest effective dose for the shortest possible duration.

INTERACTIONS

Which medicines or foods can modify the effect of Voltadvance 25mg Anti-inflammatory 30 Tablets?

The use of diclofenac concomitantly with other systemic NSAIDs should be avoided.

Interactions are described with lithium, digoxin, diuretics, anticoagulants, selective serotonin reuptake inhibitors, corticosteroids, ACE inhibitors, methotrexate, ciclosporin, quinolone antibiotics, phenytoin and CYP2C9 inhibitors.

PREGNANCY AND BREASTFEEDING

Can Voltadvance 25mg Anti-inflammatory 30 Tablets be used during pregnancy and breastfeeding?

Diclofenac is contraindicated during the third trimester of pregnancy. Inhibition of prostaglandin synthesis can negatively affect pregnancy and embryo-foetal development.

Diclofenac should not be administered during breastfeeding.

WARNINGS

What are the warnings of Voltadvance 25mg Anti-inflammatory 30 Tablets?

After 2-3 days of treatment without appreciable results, consult your doctor.

Side effects can be minimized by using the lowest effective dose for the shortest possible duration.

The risk of arterial thrombotic events increases at high doses, equal to or greater than 150 mg per day, and in prolonged treatment. Elderly patients should be followed with particular attention.

CONSERVATION

How is Voltadvance 25mg Anti-inflammatory 30 Tablets stored?

This medicinal product does not require any special storage conditions.

The validity period is 5 years.

FORMAT

What is the format of Voltadvance 25mg Anti-inflammatory 30 Tablets?

30 film-coated tablets in OPA, aluminium, PVC and aluminum blisters.

DRUG LEGAL TEXT

Content responsibility

This sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note

The product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.

Data source: Farmadati Italia

Website: www.farmadati.it

The Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.

The Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.